(Total Views: 963)
Posted On: 09/23/2021 3:15:29 PM
Post# of 148899
Here is a reading list:
Dosage for other indications. For some indications only a single dose is required, but for others the dose may need to be repeated 2-3 times.
2. L Caly et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020 April 3 (epub).
3. National Institutes of Health (NIH). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at: https://covid19treatmentguidelines.nih.gov/. Accessed January 18, 2021.
4. FDA letter to stakeholders: do not use ivermectin intended for animals as treatment for COVID-19 in humans. Available at: https://www.fda.gov/animal-veterinary/product...-19-humans. Accessed August 29, 2020.
5. JC Rajter et al. Use of ivermectin is associated with lower mortality in hospitalized patients with COVID-19 (ICON study). Chest 2020 October 12 (epub; in press).
6. G Momekov and D Momekova. Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens.
MedRxiv 2020 May 22. Available at: https://www.medrxiv.org/content/10.1101/2020....20061804v2. Accessed October 26, 2020.
7. R Mahmud et al. Clinical trial of ivermectin plus doxycycline for the treatment of confirmed COVID-19 infection. ClinicalTrials.gov. Available at:
https://clinicaltrials.gov/ct2/show/results/NCT04523831. Accessed October 26, 2020.
8. HA Hashim et al. Controlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad, Iraq. MedRxiv 2020 October 27 (epub). Available at:
https://www.medrxiv.org/content/10.1101/2020....20219345v1. Accessed November 4, 2020.
9. S Ahmed et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 2021; 103:214.
10. AZK Chachar et al. Effectiveness of ivermectin in SARS-CoV-2/COVID-19 patients. Int J of Sci 2020; 9:31.
11. ATMM Chowdhury et al. A randomized trial of ivermectin-doxycycline and hydroxychloroquine-azithromycin therapy on COVID-19 patients. Research Square 2020 (preprint).
12. P Soto-Becerra et al. Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using
observational data from a nationwide healthcare system in Peru. medRxiv 2020 October 14 (epub).
13. A Elgazzar et al. Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic. Research Square 2020 December 28 (epub).
14. MS Niaee et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial. Research Square 2020 November 24 (epub).
15. E Lopez-Medina et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial. JAMA 2021; 325:1426
6. A Bhimraj et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Available at: https://www.idsociety.org/practiceguideline/c...anagement/. Accessed March 29, 2021.
17. YM Roman et al. Ivermectin for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. medRxiv 2021 May 25 (epub). Available at:
https://www.medrxiv.org/content/10.1101/2021....21257595v1. Accessed May 27, 2021.
18. A Hill et al. Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Open Forum Infect Dis 2021 July 6 (accepted manuscript).
19. J Vallejos et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis 2021; 21:635.
20. News Release. AMA, APhA, ASHP statement on ending use of ivermectin to treat COVID-19. Available at: https://www.ama-assn.org/press-center/press-r...t-covid-19. Accessed September 7, 2021.
21. CDC Health Advisory. Rapid increase in ivermectin prescriptions and reports of severe illness associated with use of products containing ivermectin to prevent or treat COVID-19. Available
at: https://emergency.cdc.gov/han/2021/pdf/CDC_HAN_449.pdf. Accessed September 7, 2021.
Dosage for other indications. For some indications only a single dose is required, but for others the dose may need to be repeated 2-3 times.
2. L Caly et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020 April 3 (epub).
3. National Institutes of Health (NIH). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at: https://covid19treatmentguidelines.nih.gov/. Accessed January 18, 2021.
4. FDA letter to stakeholders: do not use ivermectin intended for animals as treatment for COVID-19 in humans. Available at: https://www.fda.gov/animal-veterinary/product...-19-humans. Accessed August 29, 2020.
5. JC Rajter et al. Use of ivermectin is associated with lower mortality in hospitalized patients with COVID-19 (ICON study). Chest 2020 October 12 (epub; in press).
6. G Momekov and D Momekova. Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens.
MedRxiv 2020 May 22. Available at: https://www.medrxiv.org/content/10.1101/2020....20061804v2. Accessed October 26, 2020.
7. R Mahmud et al. Clinical trial of ivermectin plus doxycycline for the treatment of confirmed COVID-19 infection. ClinicalTrials.gov. Available at:
https://clinicaltrials.gov/ct2/show/results/NCT04523831. Accessed October 26, 2020.
8. HA Hashim et al. Controlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad, Iraq. MedRxiv 2020 October 27 (epub). Available at:
https://www.medrxiv.org/content/10.1101/2020....20219345v1. Accessed November 4, 2020.
9. S Ahmed et al. A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 2021; 103:214.
10. AZK Chachar et al. Effectiveness of ivermectin in SARS-CoV-2/COVID-19 patients. Int J of Sci 2020; 9:31.
11. ATMM Chowdhury et al. A randomized trial of ivermectin-doxycycline and hydroxychloroquine-azithromycin therapy on COVID-19 patients. Research Square 2020 (preprint).
12. P Soto-Becerra et al. Real-world effectiveness of hydroxychloroquine, azithromycin, and ivermectin among hospitalized COVID-19 patients: results of a target trial emulation using
observational data from a nationwide healthcare system in Peru. medRxiv 2020 October 14 (epub).
13. A Elgazzar et al. Efficacy and safety of ivermectin for treatment and prophylaxis of COVID-19 pandemic. Research Square 2020 December 28 (epub).
14. MS Niaee et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial. Research Square 2020 November 24 (epub).
15. E Lopez-Medina et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial. JAMA 2021; 325:1426
6. A Bhimraj et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Available at: https://www.idsociety.org/practiceguideline/c...anagement/. Accessed March 29, 2021.
17. YM Roman et al. Ivermectin for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials. medRxiv 2021 May 25 (epub). Available at:
https://www.medrxiv.org/content/10.1101/2021....21257595v1. Accessed May 27, 2021.
18. A Hill et al. Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection. Open Forum Infect Dis 2021 July 6 (accepted manuscript).
19. J Vallejos et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis 2021; 21:635.
20. News Release. AMA, APhA, ASHP statement on ending use of ivermectin to treat COVID-19. Available at: https://www.ama-assn.org/press-center/press-r...t-covid-19. Accessed September 7, 2021.
21. CDC Health Advisory. Rapid increase in ivermectin prescriptions and reports of severe illness associated with use of products containing ivermectin to prevent or treat COVID-19. Available
at: https://emergency.cdc.gov/han/2021/pdf/CDC_HAN_449.pdf. Accessed September 7, 2021.
(5)
(0)Scroll down for more posts ▼
